Document and Entity Information
Document and Entity Information - shares | 6 Months Ended | |
Jun. 30, 2019 | May 31, 2023 | |
Details | ||
Registrant CIK | 0001379245 | |
Fiscal Year End | --12-31 | |
Document Type | 10-Q | |
Document Quarterly Report | true | |
Document Period End Date | Jun. 30, 2019 | |
Document Transition Report | false | |
Entity File Number | 333-139045 | |
Entity Registrant Name | ENIGMA-BULWARK, LTD. | |
Entity Incorporation, State or Country Code | NV | |
Entity Tax Identification Number | 46-4733512 | |
Entity Address, Address Line One | 3415 South Sepulveda Blvd., Suite 1100-#1234 | |
Entity Address, City or Town | Los Angeles | |
Entity Address, State or Province | CA | |
Entity Address, Postal Zip Code | 90034 | |
Phone Fax Number Description | Registrant's telephone number | |
City Area Code | 888 | |
Local Phone Number | 287-9994 | |
Entity Current Reporting Status | No | |
Entity Interactive Data Current | No | |
Entity Filer Category | Non-accelerated Filer | |
Entity Small Business | true | |
Entity Emerging Growth Company | true | |
Entity Ex Transition Period | false | |
Entity Shell Company | false | |
Entity Common Stock, Shares Outstanding | 136,591,547 | |
Amendment Flag | false | |
Document Fiscal Year Focus | 2019 | |
Document Fiscal Period Focus | Q2 |
Consolidated Balance Sheets
Consolidated Balance Sheets - USD ($) | Jun. 30, 2019 | Dec. 31, 2018 |
ASSETS | ||
Investment in securities | $ 1,207 | $ 2,413 |
Property and equipment, net | 474 | 710 |
Finite-Lived Intangible Assets, Net | 30,366 | 31,166 |
Other assets | 5,800 | 5,800 |
TOTAL ASSETS | 37,847 | 40,089 |
Current liabilities | ||
Accounts payable and accrued expenses | 1,831,123 | 1,692,746 |
Notes and loans payable | 169,605 | 169,605 |
Notes payable, convertible | 500,000 | 500,000 |
Notes payable, convertible, related party | 848,985 | 728,985 |
Related party payables | 1,008,197 | 798,261 |
Total current liabilities | 4,357,910 | 3,889,597 |
Long-term liabilities | ||
Notes payable, related party, convertible, net of unamortized discount | 2,443,720 | 2,443,720 |
Total long-term liabilities | 2,443,720 | 2,443,720 |
Total liabilities | 6,801,630 | 6,333,317 |
Stockholders' deficit | ||
Preferred Stock | 0 | 0 |
Common stock, $0.001 par value, 250,000,000 shares authorized, 77,382,753 issued and outstanding as of June 30, 2019, and December 31, 2018 | 77,382 | 77,382 |
Additional paid in capital | 11,063,522 | 11,057,370 |
Subscriptions receivable | (7,000) | (7,000) |
Accumulated deficit | (17,893,535) | (17,418,034) |
Accumulated comprehensive income | (4,152) | (2,946) |
Total stockholders' deficit | (6,763,783) | (6,293,228) |
TOTAL LIABILITIES AND STOCKHOLDERS' DEFICIT | $ 37,847 | $ 40,089 |
Consolidated Balance Sheets - P
Consolidated Balance Sheets - Parenthetical - $ / shares | Jun. 30, 2019 | Dec. 31, 2018 |
Consolidated Balance Sheets | ||
Preferred Stock, Par or Stated Value Per Share | $ 0.001 | $ 0.001 |
Preferred Stock, Shares Authorized | 25,000,000 | 25,000,000 |
Common Stock, Par or Stated Value Per Share | $ 0.001 | $ 0.001 |
Common Stock, Shares Authorized | 250,000,000 | 250,000,000 |
Common Stock, Shares Issued and Outstanding | 77,382,753 | 77,382,753 |
Consolidated Statements of Inco
Consolidated Statements of Income - USD ($) | 3 Months Ended | 6 Months Ended | ||
Jun. 30, 2019 | Jun. 30, 2018 | Jun. 30, 2019 | Jun. 30, 2018 | |
Consolidated Statements of Income | ||||
General and administrative expenses | $ 211,128 | $ 152,702 | $ 366,439 | $ 304,465 |
Operating loss | (211,128) | (152,702) | (366,439) | (304,465) |
Other expenses | ||||
Interest expense | (55,204) | (51,105) | (109,062) | (99,789) |
Discount amortization | 0 | (21,567) | 0 | (42,897) |
Total other expenses | (55,204) | (72,672) | (109,062) | (142,686) |
Net loss | (266,332) | (225,374) | (475,501) | (447,151) |
Comprehensive loss | ||||
Unrealized loss on securities | 0 | 0 | (1,206) | (2,412) |
Net comprehensive loss | 0 | 0 | (1,206) | (2,412) |
Net loss and comprehensive loss | $ (266,332) | $ (225,374) | $ (476,707) | $ (449,563) |
Net loss per share - basic and diluted | $ (0.003) | $ (0.003) | $ (0.006) | $ (0.006) |
Weighted average common shares outstanding - basic and diluted | 77,382,753 | 69,382,753 | 76,899,328 | 69,382,753 |
Consolidated Statement of Stock
Consolidated Statement of Stockholders' Deficit - USD ($) | Common Stock, Shares | Common Stock, Value | Paid In Capital | Subscriptions Receivable | Accumulated Deficit | AOCI | Total |
Equity Balance at Dec. 31, 2017 | $ 69,382 | $ 11,025,120 | $ 0 | $ (18,511,900) | $ (534) | $ (7,417,932) | |
Equity Balance, Shares at Dec. 31, 2017 | 69,382,753 | ||||||
Net Loss | (221,777) | (224,189) | |||||
Comprehensive Loss | (2,412) | ||||||
Equity Balance at Mar. 31, 2018 | 69,382 | 11,025,120 | 0 | (18,733,677) | (2,946) | (7,642,121) | |
Equity Balance, Shares at Mar. 31, 2018 | 69,382,753 | ||||||
Net Loss | (225,374) | (225,374) | |||||
Equity Balance at Jun. 30, 2018 | 69,382 | 11,025,120 | 0 | (18,959,051) | (2,946) | (7,867,495) | |
Equity Balance, Shares at Jun. 30, 2018 | 69,382,753 | ||||||
Equity Balance at Dec. 31, 2018 | 77,382 | 11,057,370 | (7,000) | (17,418,034) | (2,946) | (6,293,228) | |
Equity Balance, Shares at Dec. 31, 2018 | 77,382,753 | ||||||
Amortization of restricted stock award | 750 | ||||||
Net Loss | (209,169) | (210.375) | |||||
Comprehensive Loss | (1,206) | ||||||
Equity Balance at Mar. 31, 2019 | 77,382 | 11,058,120 | (7,000) | (17,627,203) | (4,152) | (6,502,853) | |
Equity Balance, Shares at Mar. 31, 2019 | 77,382,753 | ||||||
Amortization of restricted stock award | 750 | 750 | |||||
Net Loss | (266,332) | (266,332) | |||||
Comprehensive Loss | 0 | ||||||
Equity Balance at Jun. 30, 2019 | $ 77,382 | 11,063,522 | $ (7,000) | $ (17,893,535) | $ (4,152) | (6,763,783) | |
Equity Balance, Shares at Jun. 30, 2019 | 77,382,753 | ||||||
Amortization of stock options | $ 4,652 | $ 4,652 |
Consolidated Statements of Cash
Consolidated Statements of Cash Flows - USD ($) | 6 Months Ended | |
Jun. 30, 2019 | Jun. 30, 2018 | |
Cash flow from operating activities | ||
Net income (loss) and comprehensive income (loss) | $ (476,707) | $ (449,563) |
Comprehensive income (loss) | (1,206) | (2,412) |
Net loss | (475,501) | (447,151) |
Adjustments to reconcile net loss to net cash provided by operating activities | ||
Stock compensation/amortization of deferred compensation | 6,152 | 0 |
Accruals converted to related party loans | 120,000 | 257,975 |
Depreciation and amortization | 1,036 | 236 |
Discount amortization | 0 | 42,897 |
Changes in operating assets and liabilities | ||
Increase in accounts payable and accrued expenses | 138,377 | 125,172 |
Increase in related party payables | 209,936 | 20,871 |
Net cash provided by operating activities | 0 | 0 |
Net change in cash | 0 | 0 |
Cash - beginning of period | 0 | 0 |
Cash - end of period | 0 | 0 |
NONCASH ACTIVITIES | ||
Conversion of related party payable to related party convertible note payable | 120,000 | 257,975 |
SUPPLEMENTAL DISCLOSURES OF CASH FLOW INFORMATION | ||
Interest paid | 0 | 0 |
Income taxes paid | $ 0 | $ 0 |
Overview and Nature of Business
Overview and Nature of Business | 6 Months Ended |
Jun. 30, 2019 | |
Notes | |
Overview and Nature of Business | NOTE 1. OVERVIEW AND NATURE OF BUSINESS The accompanying unaudited consolidated financial statements of Enigma-Bulwark, Ltd., (the “Company” or “Enigma”) have been prepared in accordance with generally accepted accounting principles. The preparation of consolidated financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and that effect the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. These interim consolidated financial statements should be read in conjunction with the audited consolidated financial statements and notes for the year ended December 31, 2018. Notes to the consolidated financial statements that would substantially duplicate the disclosures contained in the audited consolidated financial statements have been omitted. The Company was incorporated in Nevada on September 30, 2005, and is headquartered in Los Angeles, California. Formerly PearTrack Security Systems, Inc., the Company’s name was changed to Enigma-Bulwark, Ltd., on October 9, 2019, pursuant to a majority of the Company’s shareholders and unanimous resolution of the board of directors. Enigma-Bulwark, Ltd. (“Enigma” or “Company”) is a security and risk management company that provides physical security, technology-systems integration, and risk management advisory services. Services offered to assess and mitigate risk include security guards, risk management analysis, and proprietary and third-party technology and software. Target markets include corporations, governments and individuals across the globe. As of June 30, 2019, the Company was structured with three wholly-owned subsidiaries: PearTrack Systems Group, Ltd. (“PTSG”), Ecologic Products, Inc. (“EPI”), and Ecologic Car Rentals, Inc. (“ECR”), all Nevada corporations. The Company’s current business activities are diversified into two specific markets: security and risk management, and remote/mobile asset tracking products. The Company intends to provide a unique solution to security issues in the intermodal shipping container marketplace, with its patented container tracking and locking system, EnigmaLok (formerly PearLoxx), the rights of which were licensed to the Company in perpetuity in 2015. Through the subsidiaries, Ecologic Car Rentals, Inc. and Ecologic Products, Inc., the Company continues its pursuits for strategic opportunities for its shareholders, as management believes that the brands have value for companies with environmentally-friendly consumer-related products and services. Going Concern The Company has incurred losses since inception resulting in a current period net loss of $476,707, an accumulated deficit of $17,893,535, and a working capital deficit of $4,357,910 as of June 30, 2019, and further losses are anticipated. The Company’s ability to continue as a going concern is dependent upon its ability to generate profitable operations in the future and/or to obtain the necessary financing to meet its obligations and repay its liabilities arising from normal business operations when they come due, which may not be available at commercially reasonable terms. There can be no assurance that the Company will be able to continue to raise funds, in which case the Company may be unable to meet its obligations and the Company may cease operations. These factors, among others, raise substantial doubt about the Company’s ability to continue as a going concern. The consolidated financial statements reflect all adjustments consisting of normal recurring adjustments, which, in the opinion of management, are necessary for a fair presentation of the results for the periods shown. The consolidated financial statements do not include any adjustments relating to the recoverability and classification of recorded assets, or the amounts of and classification of liabilities that might be necessary in the event the Company cannot continue as a going concern. |
Significant Accounting Policies
Significant Accounting Policies | 6 Months Ended |
Jun. 30, 2019 | |
Notes | |
Significant Accounting Policies | NOTE 2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Basis of Presentation This summary of significant accounting policies is presented to assist in understanding the Company’s consolidated financial statements. These accounting policies conform to accounting principles, generally accepted in the United States of America, and have been consistently applied in the preparation of the consolidated financial statements. The Company’s fiscal year end is December 31. Principles of Consolidation The consolidated financial statements include the accounts of the Company and its wholly-owned subsidiaries. All intercompany balances and transactions have been eliminated. Use of Estimates The preparation of consolidated financial statements in conformity with US GAAP requires management to make estimates and assumptions that affect the reported amount of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. Management routinely makes judgments and estimates about the effects of matters that are inherently uncertain. Estimates that are critical to the accompanying consolidated financial statements include the estimates related to asset impairments of long-lived assets and investments, classification of expenditures as either an asset or an expense, valuation of deferred tax assets, and the likelihood of loss contingencies. Management bases its estimates and judgments on historical experience and on various other factors that are believed to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources. Estimates and assumptions are revised periodically, and the effects of revisions are reflected in the consolidated financial statements in the period it is determined to be necessary. Actual results could differ from these estimates. Fair Value Hierarchy The Company utilizes the three-level valuation hierarchy for the recognition and disclosure of fair value measurements. The categorization of assets and liabilities within this hierarchy is based upon the lowest level of input that is significant to the measurement of fair value. The three levels of the hierarchy consist of the following: Level 1: Level 2: Level 3: The Company’s investment in securities are classified as Level 1 assets, and were valued using the quoted prices in the active market (Note 3). Fair Value of Financial Instruments As of June 30, 2019, and December 31, 2018, respectively, the carrying values of Company’s Level 1 financial instruments including cash and cash equivalents, investments in securities, accounts receivable, accounts payable, and short-term debt approximate fair value. The fair value of Level 3 instruments is calculated as the net present value of expected cash flows based on externally provided or obtained inputs. Certain Level 3 instruments may also be based on sales prices of similar assets. The Company’s fair value calculations take into consideration the credit risk of both the Company and its counterparties as of the date of valuation. Cash and Cash Equivalents The Company considers cash in banks, deposits in transit, and highly-liquid debt instruments purchased with original maturities of three months or less to be cash and cash equivalents. As of June 30, 2019, and December 31, 2018, the Company had no cash equivalents. Investments in Securities Investments in securities are accounted for using the equity method if the investment provides the Company the ability to exercise significant influence, but not control, over an investee. Significant influence is generally deemed to exist if the Company has an ownership interest in the voting stock of the investee between 20% and 50%, although other factors, such as representation on the investee's board of directors, are considered in determining whether the equity method is appropriate. All other equity investments, which consist of investments for which the Company does not possess the ability to exercise significant influence, are accounted for under the mark to market method. Under the mark to market method of accounting, investments are marked to market, with unrealized gains and losses being excluded from earnings and reflected as a component of other comprehensive income. Property and Equipment Property and equipment is carried at the cost of acquisition or construction and depreciated over the estimated useful lives of the assets. Costs associated with repairs and maintenance are expensed as incurred. Costs associated with improvements which extend the life, increase the capacity or improve the efficiency of the Company’s property and equipment are capitalized and depreciated over the remaining life of the related asset. Gains and losses on dispositions of equipment are reflected in operations. Depreciation is provided using the straight-line method over the estimated useful lives of the assets, which are 5 to 7 years. Intangible Assets Product processes, patents and customer lists are amortized on a straight-line basis over their estimated useful lives between 4 to 20 years. Application development stage costs for significant internally developed software projects are capitalized and amortized on a straight-line basis over the useful life, between 2 to 5 years. Costs to extend and maintain patents and trademarks are charged directly to expense as incurred. Impairment of Long-Lived Assets The Company evaluates long-lived assets for impairment whenever events or changes in circumstances indicate that their net book value may not be recoverable. When such factors and circumstances exist, the Company compares the projected undiscounted future cash flows associated with the related asset or group of assets over their estimated useful lives against their respective carrying amount. Impairment, if any, is based on the excess of the carrying amount over the fair value, based on market value when available, or discounted expected cash flows, of those assets and is recorded in the period in which the determination is made. Due to the Company’s recurring losses and lack of revenue from its intellectual properties, its intellectual properties were evaluated for impairment, and it was determined that expected future cash flows were sufficient for recoverability of the assets at December 31, 2018. Convertible Debt The Company recognizes the advantageous value of conversion rights attached to convertible debt. Such rights give the debt holder the ability to convert debt into common stock at a price per share that is less than the trading price to the public on the date of the debt. The beneficial value is calculated as the intrinsic value (the market price of the stock at the commitment date in excess of the conversion rate) of the beneficial conversion feature of the debt, and is recorded as a discount to the related debt and an addition to additional paid in capital. The discount is amortized over the remaining outstanding period of related debt using the interest method. Revenue Recognition Revenue is recognized only when the price is fixed or determinable, persuasive evidence of an arrangement exists, the service has been provided, and collectability is reasonably assured. The Company’s revenue is generated from limited customer contracts for its tracking units and system. In addition, the Company provides consulting services as an additional revenue source. As of June 30, 2019, the Company has not commenced its principal operations, generating limited test sales of its security product line. Income Taxes Deferred tax assets and liabilities are recognized for the estimated future tax consequences attributable to temporary differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases. These assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which the temporary differences are expected to reverse. The Company has net operating loss carryforwards available to reduce future taxable income. Future tax benefits for these net operating loss carryforwards are recognized to the extent that realization of these benefits is considered more likely than not. To the extent that the Company will not realize a future tax benefit, a valuation allowance is established. As of June 30, 2019, the Company had not yet filed its 2013 through 2018 annual corporate income tax returns, which were filed in April 2022. Due to the Company’s recurring losses, no corporate income taxes are due for these periods. Net Income (Loss) Per Common Share Basic earnings (loss) per share is calculated by dividing net income (loss) by the weighted average number of common shares outstanding for the period. Diluted earnings (loss) per share is calculated by dividing net income (loss) by the weighted average number of common shares and dilutive common stock equivalents outstanding. During the periods when anti-dilutive, common stock equivalents, if any, are not considered in the computation. Other Comprehensive Income (Loss) Other comprehensive income includes unrealized gains and losses on securities available for sale, and unrealized gains and losses resulting from foreign exchange differences. During the six months ended June 30, 2019 and 2018, respectively, other comprehensive losses of $1,206 and $2,412 have been recognized. As of June 30, 2019 and 2018, respectively, other comprehensive losses of $4,152 and $2,946 has been accumulated. The following represents the accumulated comprehensive income activity: Unrealized Foreign Currency Exchange Unrealized Securities Gains (Losses) Total Accumulated Other Comprehensive Income (Loss) Balance, December 31, 2017 $ 6,703 $ (7,237 ) $ (534 ) Gain (loss) -- (2,412 ) (2,412 ) Balance, June 30, 2018 $ 6,703 $ (9,649 ) $ (2,946 ) Balance, December 31, 2018 $ 6,703 $ (9,649 ) $ (2,946 ) Gain (loss) -- (1,206 ) (1,206 ) Balance, June 30, 2019 $ 6,703 $ (10,855 ) $ (4,152 ) Stock Based Compensation The Company records stock-based compensation using the fair value method. All transactions in which goods or services are the consideration received for the issuance of equity instruments are accounted for based on the fair value of the consideration received or the fair value of the equity instrument issued, whichever is more reliably measurable. Equity instruments issued to employees and the cost of the services received as consideration are measured and recognized based on the fair value of the equity instruments issued. Recent Accounting Pronouncements The Company evaluates the pronouncements of various authoritative accounting organizations, primarily the Financial Accounting Standards Board (“FASB”), the US Securities and Exchange Commission (“SEC”), and the Emerging Issues Task Force (“EITF”), to determine the impact of new pronouncements on US GAAP and the impact on the Company. The Company has recently adopted the following new accounting standards: Adopted: In January 2016, the FASB issued ASU No. 2016-01, Financial Instruments-Overall (Subtopic 825-10: Recognition and Measurement of Financial Assets and Financial Liabilities). The new guidance is intended to improve the recognition, measurement, presentation and disclosure of financial instruments. Among other changes, there will no longer be an available-for-sale classification for which changes in fair value are currently reported in other comprehensive income for equity securities with readily determinable fair values. Equity investments with readily determinable fair values will be measured at fair value with changes in fair value recognized in net income. ASU 2016-01 is effective for the Company beginning January 1, 2018, with early adoption not permitted. In February 2016, the FASB issued ASU No. 2016-02, Leases. Under the new guidance, lessees will be required to recognize the following for all leases (with the exception of short-term leases) at the commencement date: (a) a lease liability, which is a lessee’s obligation to make lease payments arising from a lease, measured on a discounted basis; and (b) a right-of-use asset, which is an asset that represents the lessee’s right to use, or control the use of, a specified asset for the lease term. The ASU is effective for the Company beginning January 1, 2019, with early adoption permitted. In August 2016, the FASB issued ASU No. 2016-15, Statement of Cash Flows (Topic 230), Classification of Certain Cash Receipts and Cash Payments. ASU 2016-15 provides guidance on eight specific cash flow issues, for which specific guidance had not previously been provided, with the objective of reducing the existing diversity in practice. The amendments in this update are effective for the Company for fiscal years beginning after December 15, 2017, and interim periods. Early adoption is permitted. In October 2016, the FASB issued ASU No. 2016-16, Income Taxes (Topic 740), Intra-Entity Transfers of Assets Other Than Inventory. ASU 2016-16 improves the accounting for the income tax consequences of intra-entity transfers of assets other than inventory. As part of the Board’s initiative to reduce complexity in accounting standards. The amendments in this update are effective for the Company for annual reporting periods beginning after December 15, 2017, and interim periods. Early adoption is permitted for interim or annual reporting periods for which financial statements have not been issued or made available for issuance. In January 2017, the FASB issued ASU No. 2017-01, Business Combinations (Topic 805), Clarifying the Definition of a Business. ASU 2017-01 assists entities with evaluating whether transactions should be accounted for as acquisitions (or disposals) of assets or businesses. The definition of a business affects many areas of accounting including acquisitions, disposals, goodwill, and consolidation. The amendments in this update are effective for the Company for annual periods beginning after December 15, 2017, and interim periods. Early adoption is permitted under certain conditions. In January 2017, the FASB issued ASU No. 2017-04, Intangibles-Goodwill and Other (Topic 350), Simplifying the Test for Goodwill Impairment. ASU 2017-04 simplifies how an entity is required to test goodwill for impairment by eliminating Step 2 from the goodwill impairment test, which should reduce the cost and complexity of evaluating goodwill for impairment. Step 2 measures a goodwill impairment loss by comparing the implied fair value of a reporting unit’s goodwill with the carrying amount of that goodwill. ASU 2017-04 is effective for the Company for annual periods beginning after December 15, 2019, and interim periods. Early adoption is permitted for testing performed after January 1, 2017. In May 2017, the FASB issued ASU No. 2017-09, Compensation-Stock Compensation (Topic 718), Scope of Modification Accounting. ASU 2017-09 clarifies and reduces both the (1) diversity in practice and (2) cost and complexity when applying the guidance in Topic 718 to a change to the terms or conditions of a share-based payment award. ASU 2017-09 is effective for the Company for annual periods beginning after December 15, 2017, and interim periods. Early adoption is permitted. In July 2017, the FASB issued ASU No. 2017-11, Earnings Per Share (Topic 260), Distinguishing Liabilities from Equity (Topic 480), Derivatives and Hedging (Topic 815). ASU 2017-11 addresses the complexity of accounting for certain financial instruments with down round features. Down round features are features of certain equity-linked instruments (or embedded features) that result in the strike price being reduced on the basis of the pricing of future equity offerings. ASU 2017-11 also addresses the difficulty of navigating Topic 480, Distinguishing Liabilities from Equity, because of the existence of extensive pending content in the FASB Accounting Standards Codification ® In June 2018, the FASB issued ASU No. 2018-07, Compensation-Stock Compensation (Topic 718), Improvements to Nonemployee Share-Based Payment Accounting. ASU 2018-07 expands the scope of Topic 718 to include share-based payment transactions for acquiring goods and services from nonemployees. ASU 2018-07 is effective for the Company for annual periods beginning after December 15, 2018, and interim periods. Early adoption is permitted. In July 2018, the FASB issued ASU No. 2018-11, Leases (Topic 842), Targeted Improvements. ASU 2018-11 addresses certain issues in implementing ASU 2016-02, Leases, which was issued to increase transparency ad comparability by recognizing lease assets and liabilities on the balance sheet and disclosing key information about leasing transaction. ASU 2018-11 clarifies 1) comparative reporting requirements for initial adoption; and 2) for lessors only, separating lease and non-lease components in a contract and allocating the consideration in the contract to the separate components. The amendments in this Update related to separating components of a contract affect the amendments in Update 2016-02, which is effective for the Company for annual periods beginning after December 15, 2018, and interim periods. Early adoption is permitted. Not Yet Adopted: In August 2018, the FASB issued ASU No. 2018-13, Fair Value Measurement (Topic 820), Disclosure Framework-Changes to the Disclosure Requirements for Fair Value Measurement. ASU 2018-13 modifies the disclosure requirements on fair value measurements in Topic 820, Fair Value Measurement, based on the concepts in the Concepts Statement, including the consideration of costs and benefits. ASU 2018-13 is effective for the Company for annual periods beginning after December 15, 2019, and interim periods. Early adoption is permitted. The Company is currently evaluating the impact of the application of this accounting standard update on its consolidated financial statements and related disclosures. In August 2018, the FASB issued ASU No. 2018-15, Intangibles-Goodwill and Other Internal-Use Software (Subtopic 350-40). ASU 2018-15 was issued to help entities evaluate the accounting for fees paid by a customer in a cloud computing arrangement (hosting arrangement) by providing guidance for determining when the arrangement includes a software license. ASU 2018-15 is effective for the Company for annual periods beginning after December 15, 2019, and interim periods. Early adoption is permitted. The Company is currently evaluating the impact of the application of this accounting standard update on its consolidated financial statements and related disclosures. In April 2019, the FASB issued ASU No. 2019-04, Codification Improvements to Topic 326, Financial Instruments-Credit Losses, Topic 815, Derivatives and Hedging, and Topic 825, Financial Instruments. The amendments to Topic 326 and other Topics in ASU 2019-04 clarify or address stakeholders’ specific issues about certain aspects of the amendments in Update 2016-13. The amendments to Topic 815 in ASU 2019-04 include items related to Update 2017- 12 and clarify certain aspects of Topic 815. The amendments to Topic 321 and other Topics in ASU 2019-04 relate to the amendments in Update 2016-01 and clarify certain aspects of the amendments in Update 2016-01. ASU 2019-04 is effective for the Company for annual periods beginning after December 15, 2019, and interim periods. Early adoption is permitted. The Company is currently evaluating the impact of the application of this accounting standard update on its consolidated financial statements and related disclosures. Recently Issued Accounting Standards Updates: There were various updates recently issued, most of which represented technical corrections to the accounting literature or application to specific industries. None of the updates are expected to have a material impact on the Company's consolidated financial position, results of operations or cash flows. |
Investment in Securities
Investment in Securities | 6 Months Ended |
Jun. 30, 2019 | |
Notes | |
Investment in Securities | NOTE 3. INVESTMENT IN SECURITIES As of June 30, 2019, and December 31, 2018, the Company held 12,061,854 shares of Amazonas Florestal, Ltd. (OTC: AZFL) common stock. The securities are classified as Level 1 investments (Note 2, Fair Value Hierarchy), and are valued using the quoted market prices. During the six months ended June 30, 2019 and 2018, respectively, $1,206 and $2,412 in unrealized losses were recognized and included as part of comprehensive income (loss). As of June 30, 2019, and December 31, 2018, respectively, $10,855 and $9,649 in cumulative unrealized losses were recognized, and the securities held a fair value of $1,207 and $2,413. |
Property and Equipment
Property and Equipment | 6 Months Ended |
Jun. 30, 2019 | |
Notes | |
Property and Equipment | NOTE 4. PROPERTY AND EQUIPMENT Property and equipment consists of the following: June 30, 2019 December 31, 2018 Office equipment $ 2,362 $ 2,362 Accumulated depreciation (1,888 ) (1,652 ) Property and equipment, net $ 474 $ 710 During the six months ended June 30, 2019 and 2018, respectively, $236 and $236 in depreciation was expensed. |
Intangible Assets
Intangible Assets | 6 Months Ended |
Jun. 30, 2019 | |
Notes | |
Intangible Assets | NOTE 5. INTANGIBLE ASSETS Intangible assets consists of the following: June 30, 2019 December 31, 2018 Intellectual property $ 31,500 $ 31,500 Accumulated amortization (1,134 ) (334 ) Intellectual property, net $ 30,366 $ 31,166 During the six months ended June 30, 2019 and 2018, respectively, $800 and $0 in amortization was expensed. |
Accounts Payable and Accrued Ex
Accounts Payable and Accrued Expenses | 6 Months Ended |
Jun. 30, 2019 | |
Notes | |
Accounts Payable and Accrued Expenses | NOTE 6. ACCOUNTS PAYABLE AND ACCRUED EXPENSES Accounts payable and accrued expenses consist of: June 30, 2019 December 31, 2018 Accounts payable-vendors $ 721,896 $ 713,581 Accrued payroll and taxes 101,995 80,995 Accrued interest 1,006,453 897,391 Other liabilities 779 779 Total accounts payable and accrued expenses $ 1,831,123 $ 1,692,746 |
Notes and Loans Payable
Notes and Loans Payable | 6 Months Ended |
Jun. 30, 2019 | |
Notes | |
Notes and Loans Payable | NOTE 7. NOTES AND LOANS PAYABLE Notes and loans payable consists of the following: June 30, 2019 December 31, 2018 Loans payable $ 44,605 $ 44,605 Notes payable, short term 125,000 125,000 Total notes and loans payable 169,605 169,605 Notes payable, short-term, convertible 500,000 500,000 Total $ 669,605 $ 669,605 Notes payable includes the following convertible promissory notes at June 30, 2019, and December 31, 2018: Description Principal Interest Rate (%) Conversion Rate Maturity Date Matrix Advisors, Inc. $ 500,000 5 $0.25 12/31/2015 [1] Total convertible notes payable $ 500,000 [1] No change in terms of promissory note due to breach. The debt was converted in November 2021. During the six months ended June 30, 2019, and the year ended December 31, 2018, respectively, interest in the amount of $25,786 and $60,797 was expensed. As of June 30, 2019, and December 31, 2018, respectively, interest in the amount of $376,852 and $351,066 has been accrued and is included as part of accrued expenses on the accompanying consolidated balance sheets. |
Related Party Transactions
Related Party Transactions | 6 Months Ended |
Jun. 30, 2019 | |
Notes | |
Related Party Transactions | NOTE 8. RELATED PARTY TRANSACTIONS Related party transactions consists of the following: June 30, 2019 December 31, 2018 Notes payable, convertible, short-term $ 848,985 $ 728,985 Notes payable, convertible, long-term 2,443,720 2,443,720 Total notes payable 3,292,705 3,172,705 Accrued compensation 855,491 645,555 Reimbursable expenses/cash advances payable 152,706 152,706 Total related party payable 1,008,197 798,261 Total related party transactions $ 4,300,902 $ 3,970,966 Related party notes payable consists of the following convertible notes payable at June 30, 2019, and December 31, 2018: Description Principal Interest Rate (%) Conversion Rate Maturity Date Short-term: Huntington Chase Financial Group $ 413,913 7 $0.05 1 year from demand [1] Huntington Chase LLC 160,000 5 $0.05 12/31/2023 William Nesbitt 86,317 5 $0.05 Funding [2] Kasper Group, Ltd. 188,755 7 $0.05 1 year from demand [1] Total short-term 848,985 Long-term: Huntington Chase Financial Group 1,123,000 5 $0.05 12/31/2021 E. William Withrow Jr. 894,256 5 $0.05 12/31/2021 John Macey 426,464 4 $0.25 12/31/2023 Total long-term 2,443,720 Total convertible notes payable $ 3,292,705 [1] No demand has been made [2] The requisite funding goals for repayment have not been met. All outstanding promissory notes to related parties bear interest at a rate of 5 to 7 percent per annum, are due and payable within between one (1) year of written demand to December 31, 2023, or upon certain equity funding, and are convertible into the Company’s common stock at a price of between $0.05 to $0.25 per share. As of June 30, 2019, and December 31, 2018, respectively, affiliates and related parties are due a total of $4,300,902 and $3,970,966, which is comprised of promissory notes to related parties in the amount of $3,292,705 and $3,172,705; accrued compensation in the amount of $855,491 and $645,555; and reimbursable expenses/cash advances to the Company in the amount of $152,706 and $152,706; for a net increase (decrease) of $329,936 and ($1,182,536). During the six months ended June 30, 2019, and the year ended December 31, 2018, respectively, promissory notes to related parties increased (decreased) by $120,000 and ($1,391,569), unamortized discounts decreased by $0 and $81,469, and accrued compensation increased by $209,936 and $127,564. During the six months ended June 30, 2019, and the year ended December 31, 2018, respectively, promissory notes to related parties, net of unamortized discounts, increased (decreased) by $120,000 and ($1,310,100), as a result of an increase in accrued compensation owed to related parties in the amount of $120,000 and $419,676 converted to convertible promissory notes; $0 and $188,755 reclassified from non-related party promissory notes; $0 and $2,000,000 in secured promissory notes canceled; and a decrease in unamortized discount in the amount of $0 and $81,469. During the six months ended June 30, 2019, and the year ended December 31, 2018, respectively, $329,936 and $548,240 in related party compensation was accrued, of which $120,000 and $419,676 was converted into convertible promissory notes; and $0 and $1,000 was paid; for a net increase in accrued compensation in the amount of $209,936 and $127,564. During the six months ended June 30, 2019, and the year ended December 31, 2018, respectively, $83,276 and $215,096 in interest on related party loans was expensed. As of June 30, 2019, and December 31, 2018, respectively, $629,601 and $546,325 in interest on related party loans has been accrued, and is included as part of accrued expenses on the accompanying consolidated balance sheets. Agreements On May 1, 2019, the Company entered into Consulting Agreement with Mr. David Rocke. The agreement is for an initial term of three (3) years, and provides a base compensation of $150,000 per year, to be deferred until the Company reaches certain funding goals, as well as 12.5% of Enigma-Bulwark Security, Inc. adjusted gross earnings, as defined within the agreement. In addition, the agreement includes a grant of 6,875,093 options to purchase shares of the Company’s common stock, valued at $39,875 using the Black-Scholes method, at an exercise price of $0.005 per share. The options are exercisable for a period of five (5) years, of which 50% vest when certain performance goals are met, and the remainder vest when certain funding goals are met. The assumptions used in valuing the options were: expected term 4.00 years, expected volatility 38.58%, risk free interest rate 2.15%, and dividend yield 0%. On May 1, 2019, the Company, through its wholly-owned subsidiary, Enigma-Bulwark Risk Management, Inc., entered into Consulting Agreement with Mr. Michael Gabriele, to serve as its President, and the President of its subsidiary, Enigma-Bulwark Security, Inc. The agreement is for an initial term of three (3) years, and provides a base compensation of $175,000 per year, to be deferred until the Company reaches certain funding goals, as well as 12.5% of Enigma-Bulwark Security, Inc. adjusted gross earnings, as defined within the agreement. In addition, the agreement includes a grant of 2,750,040 options to purchase shares of the Company’s common stock, valued at $15,950 using the Black-Scholes method, at an exercise price of $0.005 per share. The options are exercisable for a period of five (5) years, of which 50% vest when certain performance goals are met, and the remainder vest when certain funding goals are met. The assumptions used in valuing the options were: expected term 4.00 years, expected volatility 38.58%, risk free interest rate 2.15%, and dividend yield 0%. |
Capital Stock
Capital Stock | 6 Months Ended |
Jun. 30, 2019 | |
Notes | |
Capital Stock | NOTE 9. CAPITAL STOCK The total number of authorized shares of common stock that may be issued by the Company is 250,000,000 shares with a par value of $0.001; and the total number of authorized preferred stock is 25,000,000 shares with a par value of $0.001. As of June 30, 2019, and December 31, 2018, the Company had 77,382,753 shares of Common Stock issued and outstanding. |
Stock Options and Awards
Stock Options and Awards | 6 Months Ended |
Jun. 30, 2019 | |
Notes | |
Stock Options and Awards | NOTE 10. STOCK OPTIONS AND AWARDS Stock Options As of June 30, 2019, and December 31, 2018, respectively, the Company had 10,227,633 and 602,500 stock options issued and outstanding. On May 15, 2019, in connection with certain consulting agreements, the Company granted 9,625,133 options to purchase shares of its Common Stock, valued at $55,825 using the Black-Scholes method, at an exercise price of $0.005 per share. The options are exercisable for a period of five (5) years, of which 50% vest when certain performance goals are met, and the remainder vest when certain funding goals are met. .The assumptions used in valuing the options were: expected term 4.00 years, expected volatility 38.58%, risk free interest rate 2.15%, and dividend yield 0%. Outstanding and Exercisable Options Remaining Exercise Price Number of Contractual Life times Number Weighted Average Exercise Price Shares (in years) of Shares Exercise Price $0.005 9,625,133 4.85 $ 48,126 $0.16 $0.10 500,000 4.30 50,000 $0.63 $3.20 102,500 1.80 328,000 $3.20 10,227,633 $ 426,126 $1.44 Options Activity Number Weighted Average of Shares Exercise Price Outstanding at December 31, 2018 602,500 $2.34 Granted 9,625,133 $0.16 Exercised -- -- Expired / Cancelled -- -- Outstanding at June 30, 2019 10,227,633 $1.44 During the six months ended June 30, 2019, and the year ended December 31, 2018, 9,624,133 and 500,000 stock options were granted, for which $55,825 and $0 in deferred stock option compensation was recorded, and $4,652 and $0 was expensed. There remained $51,173 and $0 in deferred stock option compensation at June 30, 2019, and December 31, 2018, to be expensed over the next thirty-four (34) months. Restricted Stock Awards During the six months ended June 30, 2019, and the year ended December 31, 2018, respectively, 0 and 1,000,000 restricted stock awards were granted, valued at $0 and $9,000, net of cost in the amount of $0 and $1,000; and 166,667 and 83,333 restricted stock awards vested, for which $1,500 and $750 in deferred stock compensation was expensed. As of June 30, 2019, and December 31, 2018, respectively, 750,000 and 916,667 shares remain to be vested, and $6,750 and $8,250 deferred stock compensation remains to be expensed over the next twenty-seven (27) months. Restricted Stock Awards Activity Number Deferred of Shares Compensation Outstanding at December 31, 2018 916,667 $ 8,250 Granted -- -- Vested (166,667 ) (1,500 ) Forfeited/Canceled -- -- Outstanding at June 30, 2019 750,000 $ 6,750 |
Subsequent Events
Subsequent Events | 6 Months Ended |
Jun. 30, 2019 | |
Notes | |
Subsequent Events | NOTE 11. SUBSEQUENT EVENTS The Company has evaluated the events and transactions for recognition or disclosure subsequent to June 30, 2019, and has determined that there have been no events that would require disclosure, with the exception of the following: During the period July 1, 2019, to December 31, 2022, the Company increased its loans from related parties by $1,703,966, from a total of $4,300,902 at June 30, 2019, to $6,004,868 at December 31, 2022. The increase represents (a) an increase in promissory notes in the amount of $1,703,966, as a result of (i) $110,995 reclassified from non-related party transactions, (ii) $426,464 reclassified to non-related party transactions, (iii) $3,849,845 converted from accrued compensation, (iv) an increase in discounts resulting from beneficial conversion features of $1,052,494, (v) a decrease in unamortized discount of $741,616, (vi) payments to the Company in the amount of $5,500 for stock award payments, (vii) $521,557 converted to common stock, and (viii) payments to related parties in the amount of $499,975; (b) a decrease in accrued compensation of $376,768 as a result of (i) $3,589,549 in accrued compensation, of which $3,849,845 was converted into promissory notes, (ii) $55,000 in accrued compensation reclassified to non-related party transactions, (iii) payments to the Company in the amount of $5,500 for related party stock awards, and (iv) payments to related parties in the amount of $55,972; and (c) a decrease in reimbursable expenses and cash advances to the Company of $115,732. All outstanding related party promissory notes bear interest at a rate of 5 to 7 percent per annum, are due and payable between one (1) year of written demand and December 31, 2024, or upon certain equity funding, and are convertible into the Company’s common stock at a price of between $0.05 to $0.25 per share, or the 20-day average trading price. On August 29, 2019, the Company entered into a Non-Compete, Non-Dilution and Registration Rights Agreement (“NC Agreement”) with Mr. David Rocke. The agreement is for an initial term of five (5) years, and provides as compensation a grant to purchase 6,667,000 shares of the Company’s restricted common stock, valued at $66,670, for $0.001 per share, plus the issuance of shares of the Company’s restricted common stock equal to seven percent (7%) of any issuance of common stock through May 15, 2019, originating from any financial instrument issued by the Company or its subsidiaries, in exchange for certain restrictions placed upon Mr. Rocke’s business activities. On August 29, 2019, the Company entered into a Non-Compete, Non-Dilution and Registration Rights Agreement (“NC Agreement”) with Mr. Michael Gabriele, the President of the Company’s subsidiary, Enigma-Bulwark Risk Management, Inc. The agreement is for an initial term of five (5) years, and provides as compensation a grant to purchase 6,667,000 shares of the Company’s restricted common stock, valued at $66,670, for $0.001 per share, plus the issuance of shares of the Company’s restricted common stock equal to seven percent (7%) of any issuance of common stock through May 15, 2019, originating from any financial instrument issued by the Company or its subsidiaries, in exchange for certain restrictions placed upon Mr. Gabriele’s business activities. On August 29, 2019, in connection with the Rocke and Gabriele NC Agreement, the Company issued 13,334,000 shares of its restricted common stock at $0.001 per share for cash in the amount of $13,334, plus 210,000 shares under the non-dilution provision at $0.001 per share for cash in the amount of $210. On August 30, 2019, the Company formed Enigma-Bulwark Risk Management, Inc., a Delaware corporation and wholly-owned subsidiary, and acquired 100% of the common stock of Enigma-Bulwark Security, Inc., a Delaware corporation also formed by the Company. On September 1, 2019, the Company, through its wholly-owned subsidiary, Enigma-Bulwark Risk Management, Inc., entered into Consulting Agreement with Mr. Clive Oosthuizen to serve as its Chief Executive Officer. The agreement is for an initial term of three (3) years, and provides a base compensation of $180,000 year one, $210,000 year two, and $240,000 year three, to be deferred until the Company reaches certain funding goals. In addition, the agreement includes a $25,000 signing bonus, and a grant of 1,250,000 options to purchase shares of the Company’s common stock, valued at $625 using the Black-Scholes method, at an exercise price of $0.05 per share. The options are exercisable for a period of five (5) years, and vest periodically over a period of thirty-six (36) months. The assumptions used in valuing the options were: expected term 5.75 years, expected volatility 41.3%, risk free interest rate 1.84%, and dividend yield 0%. On September 20, 2019, in connection with the exercise of certain stock options, the Company issued 4,010,470 shares of its restricted common stock to related parties at an exercise price of $0.005, for cash in the amount of $20,052. On October 1, 2019, the Company entered into a Consulting Agreement with Ms. Yinuo Jiang to serve as the Company’s Corporate Secretary effective October 8, 2019, among other duties. The agreement is for an initial term of three (3) years, and provides a base compensation of $100,000 per year, to be deferred until the Company reaches certain funding goals. In addition, the agreement includes a grant to purchase 1,000,000 shares of the Company’s restricted common stock, valued at $10,000, for $0.001 per share. On October 1, 2019, in connection with the Consulting Agreement, the Company issued 1,000,000 shares of its restricted common stock at $0.001 per share, for cash in the amount of $1,000. On October 6, 2019, pursuant to a resolution of the board of directors, the Company issued an aggregate of 6,000,000 shares of its restricted common stock, valued at $60,000, to its officers and directors at $0.001 per share, for cash in the amount of $6,000. On October 10, 2019, the Company entered into a Non-Compete, Non-Dilution and Registration Rights Agreement (“NC Agreement”) with Mr. Clive Oosthuizen, the Chief Executive Officer of the Company’s subsidiary, Enigma-Bulwark Risk Management, Inc. The agreement is for an initial term of five (5) years, and provides as compensation a grant to purchase 4,000,000 shares of the Company’s restricted common stock, valued at $360,000, for $0.001 per share, plus the issuance of shares of the Company’s restricted common stock equal to four and one-half percent (4.5%) of any issuance of common stock originating from any financial instrument issued by the Company or its subsidiaries during the term, in exchange for certain restrictions placed upon Mr. Oosthuizen’s business activities. On October 10, 2019, in connection with the Oosthuizen NC Agreement, the Company issued 4,000,000 shares of its restricted common stock at $0.001 per share for cash in the amount of $4,000. On December 20, 2019, in connection with the exercise of certain stock options, the Company issued 802,094 shares of its restricted common stock to related parties at an exercise price of $0.005 for cash in the amount of $4,010. On September 8, 2020, the Company, through its wholly-owned subsidiary, Enigma-Bulwark Risk Management, Inc., entered into a Joint Venture Agreement (the “JV Agreement”) with Prime African Security, Ltd., a South African corporation (“Prime”), to provide security and risk management services in South Africa. The joint venture formed Prime Enigma Africa (Pty) Ltd., a South African corporation (the “Joint Venture”), for which Prime owns 51% of the common stock and the Company owns 49%. The JV Agreement is for an initial term of three (3) years, and automatically renews unless canceled in writing by either party. On August 31, 2021, in connection with the conversion of related party debt in the amount of $1,238,251, the Company issued an aggregate of 23,066,991 shares of its restricted Common Stock to six (6) related parties, including three (3) officers, of which $941,096 was at a conversion price of $0.05 per share, and $297,155 was at a conversion price of $0.07 per share. On November 5, 2021, in connection with the conversion of debt in the amount of $696,301, the Company issued 2,785,205 shares of its restricted Common Stock at a conversion price of $0.25 per share. On January 1, 2022, in connection with a consulting agreement, the Company issued 2,500,000 shares of restricted common stock at $0.001 per share for cash in the amount of $2,500. Management Changes: On September 20, 2019, during a meeting of the board of directors, Mr. John D. Macy was not re-elected to the board of directors. On October 4, 2019, Mr. Clive Oosthuizen, Mr. David M. Rocke and Ms. Calli R. Bucci were appointed to the Board, to serve until the next annual meeting of the shareholders. On October 8, 2019, Ms. Calli R. Bucci resigned as Corporate Secretary. This resignation did not involve any disagreement with the Company. Ms. Yinuo “Rachel” Jiang succeeded her to serve as Corporate Secretary until the next annual meeting of the shareholders and/or until she, or her successor is duly appointed. On January 12, 2021, Mr. John L. Ogden resigned as a Board member. This resignation did not involve any disagreement with the Company. Mr. Kyle W. Withrow, the Company’s President and Chief Executive Officer, succeeded him as a director until the next annual meeting of the shareholders and/or until he, or his successor is duly appointed. On April 6, 2021, Mr. E. William Withrow Jr. resigned as Executive Chairman of the Board. His resignation did not involve any disagreement with the Company. Mr. Clive Oosthuizen, a Board member, and the President of the Company’s subsidiary, Enigma-Bulwark Risk Management, Inc., succeeded him. On April 6, 2021, Mr. Kyle W. Withrow resigned as the Company President and Chief Executive Officer, and as a Board member. His resignation did not involve any disagreement with the Company. Mr. Oosthuizen succeeded him as President and Chief Executive Officer until the next annual meeting of the shareholders and/or until he, or his successor, is duly appointed. The vacant Board member seat resulting from Mr. Withrow’s resignation will remain open until a new member is elected at the next annual meeting of the shareholders, or is duly appointed by the Board. On April 12, 2021, Mr. David Rocke resigned as a Board member and consultant. His resignation was preceded by the Company’s inquiry into Mr. Rocke’s performance in connection with his Consulting Agreement dated May 1, 2019. The vacant Board member seat resulting from Mr. Rocke’s resignation will remain open until a new member is elected at the next annual meeting of the shareholders, or is duly appointed by the Board. On April 12, 2021, Mr. Michael Gabriele resigned as President of Enigma-Bulwark Risk Management, Inc. and its subsidiaries. His resignation did not involve any disagreement with the Company. |
Significant Accounting Polici_2
Significant Accounting Policies (Policies) | 6 Months Ended |
Jun. 30, 2019 | |
Policies | |
Basis of Presentation | Basis of Presentation This summary of significant accounting policies is presented to assist in understanding the Company’s consolidated financial statements. These accounting policies conform to accounting principles, generally accepted in the United States of America, and have been consistently applied in the preparation of the consolidated financial statements. The Company’s fiscal year end is December 31. |
Principles of Consolidation | Principles of Consolidation The consolidated financial statements include the accounts of the Company and its wholly-owned subsidiaries. All intercompany balances and transactions have been eliminated. |
Use of Estimates | Use of Estimates The preparation of consolidated financial statements in conformity with US GAAP requires management to make estimates and assumptions that affect the reported amount of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. Management routinely makes judgments and estimates about the effects of matters that are inherently uncertain. Estimates that are critical to the accompanying consolidated financial statements include the estimates related to asset impairments of long-lived assets and investments, classification of expenditures as either an asset or an expense, valuation of deferred tax assets, and the likelihood of loss contingencies. Management bases its estimates and judgments on historical experience and on various other factors that are believed to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources. Estimates and assumptions are revised periodically, and the effects of revisions are reflected in the consolidated financial statements in the period it is determined to be necessary. Actual results could differ from these estimates. |
Fair Value Hierarchy | Fair Value Hierarchy The Company utilizes the three-level valuation hierarchy for the recognition and disclosure of fair value measurements. The categorization of assets and liabilities within this hierarchy is based upon the lowest level of input that is significant to the measurement of fair value. The three levels of the hierarchy consist of the following: Level 1: Level 2: Level 3: The Company’s investment in securities are classified as Level 1 assets, and were valued using the quoted prices in the active market (Note 3). |
Fair Value of Financial Instruments | Fair Value of Financial Instruments As of June 30, 2019, and December 31, 2018, respectively, the carrying values of Company’s Level 1 financial instruments including cash and cash equivalents, investments in securities, accounts receivable, accounts payable, and short-term debt approximate fair value. The fair value of Level 3 instruments is calculated as the net present value of expected cash flows based on externally provided or obtained inputs. Certain Level 3 instruments may also be based on sales prices of similar assets. The Company’s fair value calculations take into consideration the credit risk of both the Company and its counterparties as of the date of valuation. |
Cash and Cash Equivalents | Cash and Cash Equivalents The Company considers cash in banks, deposits in transit, and highly-liquid debt instruments purchased with original maturities of three months or less to be cash and cash equivalents. As of June 30, 2019, and December 31, 2018, the Company had no cash equivalents. |
Investments in Securities | Investments in Securities Investments in securities are accounted for using the equity method if the investment provides the Company the ability to exercise significant influence, but not control, over an investee. Significant influence is generally deemed to exist if the Company has an ownership interest in the voting stock of the investee between 20% and 50%, although other factors, such as representation on the investee's board of directors, are considered in determining whether the equity method is appropriate. All other equity investments, which consist of investments for which the Company does not possess the ability to exercise significant influence, are accounted for under the mark to market method. Under the mark to market method of accounting, investments are marked to market, with unrealized gains and losses being excluded from earnings and reflected as a component of other comprehensive income. |
Property and Equipment | Property and Equipment Property and equipment is carried at the cost of acquisition or construction and depreciated over the estimated useful lives of the assets. Costs associated with repairs and maintenance are expensed as incurred. Costs associated with improvements which extend the life, increase the capacity or improve the efficiency of the Company’s property and equipment are capitalized and depreciated over the remaining life of the related asset. Gains and losses on dispositions of equipment are reflected in operations. Depreciation is provided using the straight-line method over the estimated useful lives of the assets, which are 5 to 7 years. |
Intangible Assets | Intangible Assets Product processes, patents and customer lists are amortized on a straight-line basis over their estimated useful lives between 4 to 20 years. Application development stage costs for significant internally developed software projects are capitalized and amortized on a straight-line basis over the useful life, between 2 to 5 years. Costs to extend and maintain patents and trademarks are charged directly to expense as incurred. |
Impairment of Long-Lived Assets | Impairment of Long-Lived Assets The Company evaluates long-lived assets for impairment whenever events or changes in circumstances indicate that their net book value may not be recoverable. When such factors and circumstances exist, the Company compares the projected undiscounted future cash flows associated with the related asset or group of assets over their estimated useful lives against their respective carrying amount. Impairment, if any, is based on the excess of the carrying amount over the fair value, based on market value when available, or discounted expected cash flows, of those assets and is recorded in the period in which the determination is made. Due to the Company’s recurring losses and lack of revenue from its intellectual properties, its intellectual properties were evaluated for impairment, and it was determined that expected future cash flows were sufficient for recoverability of the assets at December 31, 2018. |
Convertible Debt | Convertible Debt The Company recognizes the advantageous value of conversion rights attached to convertible debt. Such rights give the debt holder the ability to convert debt into common stock at a price per share that is less than the trading price to the public on the date of the debt. The beneficial value is calculated as the intrinsic value (the market price of the stock at the commitment date in excess of the conversion rate) of the beneficial conversion feature of the debt, and is recorded as a discount to the related debt and an addition to additional paid in capital. The discount is amortized over the remaining outstanding period of related debt using the interest method. |
Revenue Recognition | Revenue Recognition Revenue is recognized only when the price is fixed or determinable, persuasive evidence of an arrangement exists, the service has been provided, and collectability is reasonably assured. The Company’s revenue is generated from limited customer contracts for its tracking units and system. In addition, the Company provides consulting services as an additional revenue source. As of June 30, 2019, the Company has not commenced its principal operations, generating limited test sales of its security product line. |
Income Taxes | Income Taxes Deferred tax assets and liabilities are recognized for the estimated future tax consequences attributable to temporary differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases. These assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which the temporary differences are expected to reverse. The Company has net operating loss carryforwards available to reduce future taxable income. Future tax benefits for these net operating loss carryforwards are recognized to the extent that realization of these benefits is considered more likely than not. To the extent that the Company will not realize a future tax benefit, a valuation allowance is established. As of June 30, 2019, the Company had not yet filed its 2013 through 2018 annual corporate income tax returns, which were filed in April 2022. Due to the Company’s recurring losses, no corporate income taxes are due for these periods. |
Net Income (Loss) Per Common Share | Net Income (Loss) Per Common Share Basic earnings (loss) per share is calculated by dividing net income (loss) by the weighted average number of common shares outstanding for the period. Diluted earnings (loss) per share is calculated by dividing net income (loss) by the weighted average number of common shares and dilutive common stock equivalents outstanding. During the periods when anti-dilutive, common stock equivalents, if any, are not considered in the computation. |
Other Comprehensive Income (Loss) | Other Comprehensive Income (Loss) Other comprehensive income includes unrealized gains and losses on securities available for sale, and unrealized gains and losses resulting from foreign exchange differences. During the six months ended June 30, 2019 and 2018, respectively, other comprehensive losses of $1,206 and $2,412 have been recognized. As of June 30, 2019 and 2018, respectively, other comprehensive losses of $4,152 and $2,946 has been accumulated. The following represents the accumulated comprehensive income activity: Unrealized Foreign Currency Exchange Unrealized Securities Gains (Losses) Total Accumulated Other Comprehensive Income (Loss) Balance, December 31, 2017 $ 6,703 $ (7,237 ) $ (534 ) Gain (loss) -- (2,412 ) (2,412 ) Balance, June 30, 2018 $ 6,703 $ (9,649 ) $ (2,946 ) Balance, December 31, 2018 $ 6,703 $ (9,649 ) $ (2,946 ) Gain (loss) -- (1,206 ) (1,206 ) Balance, June 30, 2019 $ 6,703 $ (10,855 ) $ (4,152 ) |
Stock Based Compensation | Stock Based Compensation The Company records stock-based compensation using the fair value method. All transactions in which goods or services are the consideration received for the issuance of equity instruments are accounted for based on the fair value of the consideration received or the fair value of the equity instrument issued, whichever is more reliably measurable. Equity instruments issued to employees and the cost of the services received as consideration are measured and recognized based on the fair value of the equity instruments issued. |
Recent Accounting Pronouncements | Recent Accounting Pronouncements The Company evaluates the pronouncements of various authoritative accounting organizations, primarily the Financial Accounting Standards Board (“FASB”), the US Securities and Exchange Commission (“SEC”), and the Emerging Issues Task Force (“EITF”), to determine the impact of new pronouncements on US GAAP and the impact on the Company. The Company has recently adopted the following new accounting standards: Adopted: In January 2016, the FASB issued ASU No. 2016-01, Financial Instruments-Overall (Subtopic 825-10: Recognition and Measurement of Financial Assets and Financial Liabilities). The new guidance is intended to improve the recognition, measurement, presentation and disclosure of financial instruments. Among other changes, there will no longer be an available-for-sale classification for which changes in fair value are currently reported in other comprehensive income for equity securities with readily determinable fair values. Equity investments with readily determinable fair values will be measured at fair value with changes in fair value recognized in net income. ASU 2016-01 is effective for the Company beginning January 1, 2018, with early adoption not permitted. In February 2016, the FASB issued ASU No. 2016-02, Leases. Under the new guidance, lessees will be required to recognize the following for all leases (with the exception of short-term leases) at the commencement date: (a) a lease liability, which is a lessee’s obligation to make lease payments arising from a lease, measured on a discounted basis; and (b) a right-of-use asset, which is an asset that represents the lessee’s right to use, or control the use of, a specified asset for the lease term. The ASU is effective for the Company beginning January 1, 2019, with early adoption permitted. In August 2016, the FASB issued ASU No. 2016-15, Statement of Cash Flows (Topic 230), Classification of Certain Cash Receipts and Cash Payments. ASU 2016-15 provides guidance on eight specific cash flow issues, for which specific guidance had not previously been provided, with the objective of reducing the existing diversity in practice. The amendments in this update are effective for the Company for fiscal years beginning after December 15, 2017, and interim periods. Early adoption is permitted. In October 2016, the FASB issued ASU No. 2016-16, Income Taxes (Topic 740), Intra-Entity Transfers of Assets Other Than Inventory. ASU 2016-16 improves the accounting for the income tax consequences of intra-entity transfers of assets other than inventory. As part of the Board’s initiative to reduce complexity in accounting standards. The amendments in this update are effective for the Company for annual reporting periods beginning after December 15, 2017, and interim periods. Early adoption is permitted for interim or annual reporting periods for which financial statements have not been issued or made available for issuance. In January 2017, the FASB issued ASU No. 2017-01, Business Combinations (Topic 805), Clarifying the Definition of a Business. ASU 2017-01 assists entities with evaluating whether transactions should be accounted for as acquisitions (or disposals) of assets or businesses. The definition of a business affects many areas of accounting including acquisitions, disposals, goodwill, and consolidation. The amendments in this update are effective for the Company for annual periods beginning after December 15, 2017, and interim periods. Early adoption is permitted under certain conditions. In January 2017, the FASB issued ASU No. 2017-04, Intangibles-Goodwill and Other (Topic 350), Simplifying the Test for Goodwill Impairment. ASU 2017-04 simplifies how an entity is required to test goodwill for impairment by eliminating Step 2 from the goodwill impairment test, which should reduce the cost and complexity of evaluating goodwill for impairment. Step 2 measures a goodwill impairment loss by comparing the implied fair value of a reporting unit’s goodwill with the carrying amount of that goodwill. ASU 2017-04 is effective for the Company for annual periods beginning after December 15, 2019, and interim periods. Early adoption is permitted for testing performed after January 1, 2017. In May 2017, the FASB issued ASU No. 2017-09, Compensation-Stock Compensation (Topic 718), Scope of Modification Accounting. ASU 2017-09 clarifies and reduces both the (1) diversity in practice and (2) cost and complexity when applying the guidance in Topic 718 to a change to the terms or conditions of a share-based payment award. ASU 2017-09 is effective for the Company for annual periods beginning after December 15, 2017, and interim periods. Early adoption is permitted. In July 2017, the FASB issued ASU No. 2017-11, Earnings Per Share (Topic 260), Distinguishing Liabilities from Equity (Topic 480), Derivatives and Hedging (Topic 815). ASU 2017-11 addresses the complexity of accounting for certain financial instruments with down round features. Down round features are features of certain equity-linked instruments (or embedded features) that result in the strike price being reduced on the basis of the pricing of future equity offerings. ASU 2017-11 also addresses the difficulty of navigating Topic 480, Distinguishing Liabilities from Equity, because of the existence of extensive pending content in the FASB Accounting Standards Codification ® In June 2018, the FASB issued ASU No. 2018-07, Compensation-Stock Compensation (Topic 718), Improvements to Nonemployee Share-Based Payment Accounting. ASU 2018-07 expands the scope of Topic 718 to include share-based payment transactions for acquiring goods and services from nonemployees. ASU 2018-07 is effective for the Company for annual periods beginning after December 15, 2018, and interim periods. Early adoption is permitted. In July 2018, the FASB issued ASU No. 2018-11, Leases (Topic 842), Targeted Improvements. ASU 2018-11 addresses certain issues in implementing ASU 2016-02, Leases, which was issued to increase transparency ad comparability by recognizing lease assets and liabilities on the balance sheet and disclosing key information about leasing transaction. ASU 2018-11 clarifies 1) comparative reporting requirements for initial adoption; and 2) for lessors only, separating lease and non-lease components in a contract and allocating the consideration in the contract to the separate components. The amendments in this Update related to separating components of a contract affect the amendments in Update 2016-02, which is effective for the Company for annual periods beginning after December 15, 2018, and interim periods. Early adoption is permitted. Not Yet Adopted: In August 2018, the FASB issued ASU No. 2018-13, Fair Value Measurement (Topic 820), Disclosure Framework-Changes to the Disclosure Requirements for Fair Value Measurement. ASU 2018-13 modifies the disclosure requirements on fair value measurements in Topic 820, Fair Value Measurement, based on the concepts in the Concepts Statement, including the consideration of costs and benefits. ASU 2018-13 is effective for the Company for annual periods beginning after December 15, 2019, and interim periods. Early adoption is permitted. The Company is currently evaluating the impact of the application of this accounting standard update on its consolidated financial statements and related disclosures. In August 2018, the FASB issued ASU No. 2018-15, Intangibles-Goodwill and Other Internal-Use Software (Subtopic 350-40). ASU 2018-15 was issued to help entities evaluate the accounting for fees paid by a customer in a cloud computing arrangement (hosting arrangement) by providing guidance for determining when the arrangement includes a software license. ASU 2018-15 is effective for the Company for annual periods beginning after December 15, 2019, and interim periods. Early adoption is permitted. The Company is currently evaluating the impact of the application of this accounting standard update on its consolidated financial statements and related disclosures. In April 2019, the FASB issued ASU No. 2019-04, Codification Improvements to Topic 326, Financial Instruments-Credit Losses, Topic 815, Derivatives and Hedging, and Topic 825, Financial Instruments. The amendments to Topic 326 and other Topics in ASU 2019-04 clarify or address stakeholders’ specific issues about certain aspects of the amendments in Update 2016-13. The amendments to Topic 815 in ASU 2019-04 include items related to Update 2017- 12 and clarify certain aspects of Topic 815. The amendments to Topic 321 and other Topics in ASU 2019-04 relate to the amendments in Update 2016-01 and clarify certain aspects of the amendments in Update 2016-01. ASU 2019-04 is effective for the Company for annual periods beginning after December 15, 2019, and interim periods. Early adoption is permitted. The Company is currently evaluating the impact of the application of this accounting standard update on its consolidated financial statements and related disclosures. Recently Issued Accounting Standards Updates: There were various updates recently issued, most of which represented technical corrections to the accounting literature or application to specific industries. None of the updates are expected to have a material impact on the Company's consolidated financial position, results of operations or cash flows. |
Significant Accounting Polici_3
Significant Accounting Policies: Other Comprehensive Income (Loss): Comprehensive Income (Loss) (Tables) | 6 Months Ended |
Jun. 30, 2019 | |
Tables/Schedules | |
Comprehensive Income (Loss) | Unrealized Foreign Currency Exchange Unrealized Securities Gains (Losses) Total Accumulated Other Comprehensive Income (Loss) Balance, December 31, 2017 $ 6,703 $ (7,237 ) $ (534 ) Gain (loss) -- (2,412 ) (2,412 ) Balance, June 30, 2018 $ 6,703 $ (9,649 ) $ (2,946 ) Balance, December 31, 2018 $ 6,703 $ (9,649 ) $ (2,946 ) Gain (loss) -- (1,206 ) (1,206 ) Balance, June 30, 2019 $ 6,703 $ (10,855 ) $ (4,152 ) |
Property and Equipment_ Schedul
Property and Equipment: Schedule of Property and Equipment (Tables) | 6 Months Ended |
Jun. 30, 2019 | |
Tables/Schedules | |
Schedule of Property and Equipment | June 30, 2019 December 31, 2018 Office equipment $ 2,362 $ 2,362 Accumulated depreciation (1,888 ) (1,652 ) Property and equipment, net $ 474 $ 710 |
Intangible Assets_ Schedule of
Intangible Assets: Schedule of Intangible Assets (Tables) | 6 Months Ended |
Jun. 30, 2019 | |
Tables/Schedules | |
Schedule of Intangible Assets | June 30, 2019 December 31, 2018 Intellectual property $ 31,500 $ 31,500 Accumulated amortization (1,134 ) (334 ) Intellectual property, net $ 30,366 $ 31,166 |
Accounts Payable and Accrued _2
Accounts Payable and Accrued Expenses: Schedule of Accounts Payable and Accrued Expenses (Tables) | 6 Months Ended |
Jun. 30, 2019 | |
Tables/Schedules | |
Schedule of Accounts Payable and Accrued Expenses | June 30, 2019 December 31, 2018 Accounts payable-vendors $ 721,896 $ 713,581 Accrued payroll and taxes 101,995 80,995 Accrued interest 1,006,453 897,391 Other liabilities 779 779 Total accounts payable and accrued expenses $ 1,831,123 $ 1,692,746 |
Notes and Loans Payable_ Schedu
Notes and Loans Payable: Schedule of Notes and Loans Payable (Tables) | 6 Months Ended |
Jun. 30, 2019 | |
Tables/Schedules | |
Schedule of Notes and Loans Payable | June 30, 2019 December 31, 2018 Loans payable $ 44,605 $ 44,605 Notes payable, short term 125,000 125,000 Total notes and loans payable 169,605 169,605 Notes payable, short-term, convertible 500,000 500,000 Total $ 669,605 $ 669,605 |
Notes and Loans Payable_ Sche_2
Notes and Loans Payable: Schedule of Convertible Debt (Tables) | 6 Months Ended |
Jun. 30, 2019 | |
Tables/Schedules | |
Schedule of Convertible Debt | Description Principal Interest Rate (%) Conversion Rate Maturity Date Matrix Advisors, Inc. $ 500,000 5 $0.25 12/31/2015 [1] Total convertible notes payable $ 500,000 [1] No change in terms of promissory note due to breach. The debt was converted in November 2021. |
Related Party Transactions_ Sch
Related Party Transactions: Schedule of Related Party Transactions (Tables) | 6 Months Ended |
Jun. 30, 2019 | |
Tables/Schedules | |
Schedule of Related Party Transactions | June 30, 2019 December 31, 2018 Notes payable, convertible, short-term $ 848,985 $ 728,985 Notes payable, convertible, long-term 2,443,720 2,443,720 Total notes payable 3,292,705 3,172,705 Accrued compensation 855,491 645,555 Reimbursable expenses/cash advances payable 152,706 152,706 Total related party payable 1,008,197 798,261 Total related party transactions $ 4,300,902 $ 3,970,966 |
Related Party Transactions_ S_2
Related Party Transactions: Schedule of Convertible Notes Payable-Related Party (Tables) | 6 Months Ended |
Jun. 30, 2019 | |
Tables/Schedules | |
Schedule of Convertible Notes Payable-Related Party | Description Principal Interest Rate (%) Conversion Rate Maturity Date Short-term: Huntington Chase Financial Group $ 413,913 7 $0.05 1 year from demand [1] Huntington Chase LLC 160,000 5 $0.05 12/31/2023 William Nesbitt 86,317 5 $0.05 Funding [2] Kasper Group, Ltd. 188,755 7 $0.05 1 year from demand [1] Total short-term 848,985 Long-term: Huntington Chase Financial Group 1,123,000 5 $0.05 12/31/2021 E. William Withrow Jr. 894,256 5 $0.05 12/31/2021 John Macey 426,464 4 $0.25 12/31/2023 Total long-term 2,443,720 Total convertible notes payable $ 3,292,705 [1] No demand has been made [2] The requisite funding goals for repayment have not been met. |
Stock Options and Awards_ Outst
Stock Options and Awards: Outstanding and Exercisable Options (Tables) | 6 Months Ended |
Jun. 30, 2019 | |
Tables/Schedules | |
Outstanding and Exercisable Options | Outstanding and Exercisable Options Remaining Exercise Price Number of Contractual Life times Number Weighted Average Exercise Price Shares (in years) of Shares Exercise Price $0.005 9,625,133 4.85 $ 48,126 $0.16 $0.10 500,000 4.30 50,000 $0.63 $3.20 102,500 1.80 328,000 $3.20 10,227,633 $ 426,126 $1.44 |
Stock Options and Awards_ Sched
Stock Options and Awards: Schedule of Stock Options Activity (Tables) | 6 Months Ended |
Jun. 30, 2019 | |
Tables/Schedules | |
Schedule of Stock Options Activity | Options Activity Number Weighted Average of Shares Exercise Price Outstanding at December 31, 2018 602,500 $2.34 Granted 9,625,133 $0.16 Exercised -- -- Expired / Cancelled -- -- Outstanding at June 30, 2019 10,227,633 $1.44 |
Stock Options and Awards_ Sch_2
Stock Options and Awards: Schedule of Restricted Stock Awards Activity (Tables) | 6 Months Ended |
Jun. 30, 2019 | |
Tables/Schedules | |
Schedule of Restricted Stock Awards Activity | Restricted Stock Awards Activity Number Deferred of Shares Compensation Outstanding at December 31, 2018 916,667 $ 8,250 Granted -- -- Vested (166,667 ) (1,500 ) Forfeited/Canceled -- -- Outstanding at June 30, 2019 750,000 $ 6,750 |
Overview and Nature of Busine_2
Overview and Nature of Business: Going Concern (Details) - USD ($) | 3 Months Ended | 6 Months Ended | ||
Jun. 30, 2019 | Jun. 30, 2018 | Jun. 30, 2019 | Jun. 30, 2018 | |
Details | ||||
Net Loss | $ 266,332 | $ 225,374 | $ 476,707 | $ 449,563 |
Accumulated Deficit | 17,893,535 | 17,893,535 | ||
Working Capital Deficit | $ 4,357,910 | $ 4,357,910 |
Significant Accounting Polici_4
Significant Accounting Policies: Property and Equipment (Details) | Jun. 30, 2019 |
Minimum | |
Useful Life (Yrs) | 5 years |
Maximum | |
Useful Life (Yrs) | 7 years |
Significant Accounting Polici_5
Significant Accounting Policies: Intangible Assets (Details) | 6 Months Ended |
Jun. 30, 2019 | |
Minimum | |
Useful Life (Yrs) | 4 years |
Useful Life (Yrs) | 2 years |
Maximum | |
Useful Life (Yrs) | 20 years |
Useful Life (Yrs) | 5 years |
Significant Accounting Polici_6
Significant Accounting Policies: Other Comprehensive Income (Loss) (Details) - USD ($) | 6 Months Ended | |
Jun. 30, 2019 | Jun. 30, 2018 | |
Details | ||
Comprehensive Income (Loss) | $ 1,206 | $ 2,412 |
Comprehensive Income (Loss), Cumulative | $ 4,152 | $ 2,946 |
Significant Accounting Polici_7
Significant Accounting Policies: Other Comprehensive Income (Loss): Comprehensive Income (Loss) (Details) - USD ($) | 6 Months Ended | |
Jun. 30, 2019 | Jun. 30, 2018 | |
Unrealized Foreign Currency Exchange | ||
Balance | $ 6,703 | $ 6,703 |
Gain (loss) | 0 | 0 |
Balance | 6,703 | 6,703 |
Unrealized Securities Gains (Losses) | ||
Balance | (9,649) | (7,237) |
Gain (loss) | (1,206) | (2,412) |
Balance | (10,855) | (9,649) |
AOCI | ||
Balance | (2,946) | (534) |
Gain (loss) | (1,206) | (2,412) |
Balance | $ (4,152) | $ (2,946) |
Investment in Securities (Detai
Investment in Securities (Details) - OTC:AZFL Common Stock - USD ($) | 6 Months Ended | ||
Jun. 30, 2019 | Jun. 30, 2018 | Dec. 31, 2018 | |
Securities, Shares Held | 12,061,854 | 12,061,854 | |
Securities, Unrealized Gain (Loss) | $ 1,206 | $ 2,412 | |
Securities, Unrealized Gain (Loss), Cumulative | 10,855 | $ 9,649 | |
Securities, Fair Value | $ 1,207 | $ 2,413 |
Property and Equipment_ Sched_2
Property and Equipment: Schedule of Property and Equipment (Details) - USD ($) | Jun. 30, 2019 | Dec. 31, 2018 |
Details | ||
Office Equipment | $ 2,362 | $ 2,362 |
Accumulated Depreciation | (1,888) | (1,652) |
Property and Equipment, Net | $ 474 | $ 710 |
Property and Equipment (Details
Property and Equipment (Details) - USD ($) | 6 Months Ended | |
Jun. 30, 2019 | Jun. 30, 2018 | |
Details | ||
Depreciation Expense | $ 236 | $ 236 |
Intangible Assets_ Schedule o_2
Intangible Assets: Schedule of Intangible Assets (Details) - USD ($) | Jun. 30, 2019 | Dec. 31, 2018 |
Details | ||
Intellectual Property | $ 31,500 | $ 31,500 |
Accumulated Amortization | (1,134) | (334) |
Intellectual Property, Net | $ 30,366 | $ 31,166 |
Intangible Assets (Details)
Intangible Assets (Details) - USD ($) | 6 Months Ended | |
Jun. 30, 2019 | Jun. 30, 2018 | |
Details | ||
Amortization Expense | $ 800 | $ 0 |
Accounts Payable and Accrued _3
Accounts Payable and Accrued Expenses: Schedule of Accounts Payable and Accrued Expenses (Details) - USD ($) | Jun. 30, 2019 | Dec. 31, 2018 |
Details | ||
Accounts Payable-Vendors | $ 721,896 | $ 713,581 |
Accrued Payroll and Taxes | 101,995 | 80,995 |
Accrued Interest | 1,006,453 | 897,391 |
Other liabilities | 779 | 779 |
Total Accounts Payable and Accrued Expenses | $ 1,831,123 | $ 1,692,746 |
Notes and Loans Payable_ Sche_3
Notes and Loans Payable: Schedule of Notes and Loans Payable (Details) - USD ($) | Jun. 30, 2019 | Dec. 31, 2018 |
Details | ||
Loans Payable | $ 44,605 | $ 44,605 |
Notes Payable-Short Term | 125,000 | 125,000 |
Total Notes and Loans Payable | 169,605 | 169,605 |
Notes Payable-Short Term-Convertible | 500,000 | 500,000 |
Total Notes and Loans Payable-Short Term | $ 669,605 | $ 669,605 |
Notes and Loans Payable_ Sche_4
Notes and Loans Payable: Schedule of Convertible Debt (Details) | 6 Months Ended |
Jun. 30, 2019 USD ($) $ / shares | |
Convertible Note, 5% | |
Principal | $ 500,000 |
Interest Rate (%) | 5% |
Conversion Rate | $ / shares | $ 0.25 |
Maturity Date | Dec. 31, 2015 |
Convertible Note, Total | |
Principal | $ 500,000 |
Notes and Loans Payable_ Accrue
Notes and Loans Payable: Accrued Interest (Details) - USD ($) | 6 Months Ended | 12 Months Ended |
Jun. 30, 2019 | Dec. 31, 2018 | |
Details | ||
Interest Expense | $ 25,786 | $ 60,797 |
Accrued Interest | $ 376,852 | $ 351,066 |
Related Party Transactions_ S_3
Related Party Transactions: Schedule of Related Party Transactions (Details) - USD ($) | Jun. 30, 2019 | Dec. 31, 2018 |
Details | ||
Notes payable, convertible, short-term | $ 848,985 | $ 728,985 |
Notes payable, convertible, long-term, subordinate | 2,443,720 | 2,443,720 |
Total notes payable | 3,292,705 | 3,172,705 |
Accrued Compensation | 855,491 | 645,555 |
Reimbursed Expenses and Cash Advances Payable | 152,706 | 152,706 |
Total Related Party Payable | 1,008,197 | 798,261 |
Total related party transactions | $ 4,300,902 | $ 3,970,966 |
Related Party Transactions_ S_4
Related Party Transactions: Schedule of Convertible Notes Payable-Related Party (Details) | 6 Months Ended |
Jun. 30, 2019 USD ($) $ / shares | |
Huntington Chase Financial Group | |
Convertible Notes Payable, Principal | $ 413,913 |
Convertible Notes Payable, Interest Rate | 7% |
Convertible Notes Payable, Conversion Price | $ / shares | $ 0.05 |
Convertible Notes Payable, Maturity | 1 year from demand |
Huntington Chase LLC | |
Convertible Notes Payable, Principal | $ 160,000 |
Convertible Notes Payable, Interest Rate | 5% |
Convertible Notes Payable, Conversion Price | $ / shares | $ 0.05 |
Convertible Notes Payable, Maturity | 12/31/2023 |
William Nesbitt | |
Convertible Notes Payable, Principal | $ 86,317 |
Convertible Notes Payable, Interest Rate | 5% |
Convertible Notes Payable, Conversion Price | $ / shares | $ 0.05 |
Convertible Notes Payable, Maturity | Funding |
Kasper Group, Ltd | |
Convertible Notes Payable, Principal | $ 188,755 |
Convertible Notes Payable, Interest Rate | 7% |
Convertible Notes Payable, Conversion Price | $ / shares | $ 0.05 |
Convertible Notes Payable, Maturity | 1 year from demand |
Short-term, Total | |
Convertible Notes Payable, Principal | $ 848,985 |
Huntington Chase Financial Group | |
Convertible Notes Payable, Principal | $ 1,123,000 |
Convertible Notes Payable, Interest Rate | 5% |
Convertible Notes Payable, Conversion Price | $ / shares | $ 0.05 |
Convertible Notes Payable, Maturity | 12/31/2021 |
Edward W. Withrow Jr | |
Convertible Notes Payable, Principal | $ 894,256 |
Convertible Notes Payable, Interest Rate | 5% |
Convertible Notes Payable, Conversion Price | $ / shares | $ 0.05 |
Convertible Notes Payable, Maturity | 12/31/2021 |
John Macey | |
Convertible Notes Payable, Principal | $ 426,464 |
Convertible Notes Payable, Interest Rate | 4% |
Convertible Notes Payable, Conversion Price | $ / shares | $ 0.25 |
Convertible Notes Payable, Maturity | 12/31/2023 |
Long-term, Total | |
Convertible Notes Payable, Principal | $ 2,443,720 |
Convertible Notes, Related Party, Total | |
Convertible Notes Payable, Principal | $ 3,292,705 |
Related Party Transactions (Det
Related Party Transactions (Details) | 6 Months Ended |
Jun. 30, 2019 $ / shares | |
Minimum | |
Convertible Notes Payable, Interest Rate | 5% |
Convertible Notes Payable, Conversion Price | $ 0.05 |
Maximum | |
Convertible Notes Payable, Interest Rate | 7% |
Convertible Notes Payable, Conversion Price | $ 0.25 |
Related Party Transactions_ Sum
Related Party Transactions: Summary (Details) - USD ($) | 6 Months Ended | 12 Months Ended |
Jun. 30, 2019 | Dec. 31, 2018 | |
Related Party Debt, Total | ||
Due to Related Parties, Beginning of Period | $ 3,970,966 | |
Increase (Decrease) During Period, Net | 329,936 | $ (1,182,536) |
Due to Related Parties, End of Period | 4,300,902 | 3,970,966 |
Loans Payable | ||
Due to Related Parties, Beginning of Period | 3,172,705 | |
Increase (Decrease) During Period, Net | 120,000 | (1,391,569) |
Due to Related Parties, End of Period | 3,292,705 | 3,172,705 |
Accrued Compensation | ||
Due to Related Parties, Beginning of Period | 645,555 | |
Increase (Decrease), Accrued Compensation | 329,936 | 548,240 |
Increase (Decrease), Accrued Compensation, Converted to Note Payable | (120,000) | (419,676) |
Increase (Decrease) During Period, Net | 209,936 | 127,564 |
Due to Related Parties, End of Period | 855,491 | 645,555 |
Reimb Exp/Cash Advances | ||
Due to Related Parties, Beginning of Period | 152,706 | |
Due to Related Parties, End of Period | 152,706 | 152,706 |
Unamortized Discounts | ||
Increase (Decrease) During Period, Net | $ 0 | $ 81,469 |
Related Party Transactions_ Pro
Related Party Transactions: Promissory Notes (Details) - Promissory Notes - USD ($) | 6 Months Ended | 12 Months Ended |
Jun. 30, 2019 | Dec. 31, 2018 | |
Increase (Decrease) During Period, Net | $ 120,000 | $ (1,310,100) |
Increase (Decrease), Notes Payable | 120,000 | 419,676 |
Increase (Decrease), Related to Non-Related Pty | 0 | 188,755 |
Increase (Decrease), Cancellation of Debt | 0 | 2,000,000 |
Increase (Decrease), Unamortized Discounts | $ 0 | $ 81,469 |
Related Party Transactions_ Acc
Related Party Transactions: Accrued Compensation (Details) - Accrued Compensation - USD ($) | 6 Months Ended | 12 Months Ended |
Jun. 30, 2019 | Dec. 31, 2018 | |
Increase (Decrease), Accrued Compensation | $ 329,936 | $ 548,240 |
Increase (Decrease), Accrued Compensation, Converted to Note Payable | (120,000) | (419,676) |
Increase (Decrease), Accrued Compensation, Paid | 0 | (1,000) |
Increase (Decrease) During Period, Net | $ 209,936 | $ 127,564 |
Related Party Transactions_ A_2
Related Party Transactions: Accrued Interest (Details) - USD ($) | 6 Months Ended | 12 Months Ended |
Jun. 30, 2019 | Dec. 31, 2018 | |
Details | ||
Accrued Interest, Related Party, Current Period | $ 83,276 | $ 215,096 |
Accrued Interest, Related Party | $ 629,601 | $ 546,325 |
Related Party Transactions_ Agr
Related Party Transactions: Agreements (Details) | 6 Months Ended |
Jun. 30, 2019 USD ($) $ / shares shares | |
David Rocke | |
Consulting Agreement, Date | May 01, 2019 |
Consulting Agreement, Term (Yrs) | 3 |
Consulting Agreement, Compensation (Yr) | $ 150,000 |
Consulting Agreement, Profit Particpation, % | 12.50% |
Consulting Agreement, Stock Options, Shares | shares | 6,875,093 |
Consulting Agreement, Stock Options, Value | $ 39,875 |
Consulting Agreement, Stock Options, Exercise Price | $ / shares | $ 0.005 |
Consulting Agreement, Stock Options, Life (Yrs) | 5 |
Consulting Agreement, Stock Options, Value, Black-Scholes, Exp Term | 4 |
Consulting Agreement, Stock Options, Value, Black-Scholes, Volatility | 38.58% |
Consulting Agreement, Stock Options, Value, Black-Scholes, Risk Free Int Rate | 2.15% |
Consulting Agreement, Stock Options, Value, Black-Scholes, Dividend Yield | 0% |
Michael Gabriele | |
Consulting Agreement, Date | May 01, 2019 |
Consulting Agreement, Term (Yrs) | 3 |
Consulting Agreement, Compensation (Yr) | $ 175,000 |
Consulting Agreement, Profit Particpation, % | 12.50% |
Consulting Agreement, Stock Options, Shares | shares | 2,750,040 |
Consulting Agreement, Stock Options, Value | $ 15,950 |
Consulting Agreement, Stock Options, Exercise Price | $ / shares | $ 0.005 |
Consulting Agreement, Stock Options, Life (Yrs) | 5 |
Consulting Agreement, Stock Options, Value, Black-Scholes, Exp Term | 4 |
Consulting Agreement, Stock Options, Value, Black-Scholes, Volatility | 38.58% |
Consulting Agreement, Stock Options, Value, Black-Scholes, Risk Free Int Rate | 2.15% |
Consulting Agreement, Stock Options, Value, Black-Scholes, Dividend Yield | 0% |
Capital Stock (Details)
Capital Stock (Details) - $ / shares | Jun. 30, 2019 | Dec. 31, 2018 |
Details | ||
Common Stock, Shares Authorized | 250,000,000 | 250,000,000 |
Common Stock, Par or Stated Value Per Share | $ 0.001 | $ 0.001 |
Preferred Stock, Shares Authorized | 25,000,000 | 25,000,000 |
Preferred Stock, Par or Stated Value Per Share | $ 0.001 | $ 0.001 |
Common Stock, Shares, Outstanding | 77,382,753 | 77,382,753 |
Stock Options and Awards (Detai
Stock Options and Awards (Details) - shares | Jun. 30, 2019 | Dec. 31, 2018 |
Details | ||
Stock Options, Outstanding | 10,227,633 | 602,500 |
Stock Options and Awards_ Curre
Stock Options and Awards: Current Period Grants (Details) | 6 Months Ended |
Jun. 30, 2019 $ / shares shares | |
Details | |
Stock Options, Grants, Date | May 15, 2019 |
Stock Options, Grants, Shares | shares | 9,625,133 |
Stock Options, Grants, Value | $ 55,825 |
Stock Options, Grants, Exercise Price | $ 0.005 |
Stock Options, Grants, Life (Yrs) | 5 |
Stock Options, Value, Black-Scholes, Exp Term | 4 years |
Stock Options, Value, Black-Scholes, Volatility | 38.58% |
Stock Options, Value, Black-Scholes, Risk Free Int Rate | 2.15% |
Stock Options, Value, Black-Scholes, Risk Free Int Rate | 0% |
Stock Options and Awards_ Out_2
Stock Options and Awards: Outstanding and Exercisable Options (Details) | 6 Months Ended |
Jun. 30, 2019 USD ($) $ / shares shares | |
$0.005 | |
Stock Options, Number of Outstanding Options | shares | 9,625,133 |
Stock Options, Remaining Contractual Term | 4 years 10 months 6 days |
Stock Options, Exercise Price x Shares | $ | $ 48,126 |
Stock Options, Weighted Average Exercise Price | $ / shares | $ 0.16 |
$0.10 | |
Stock Options, Number of Outstanding Options | shares | 500,000 |
Stock Options, Remaining Contractual Term | 4 years 3 months 18 days |
Stock Options, Exercise Price x Shares | $ | $ 50,000 |
Stock Options, Weighted Average Exercise Price | $ / shares | $ 0.63 |
$3.20 | |
Stock Options, Number of Outstanding Options | shares | 102,500 |
Stock Options, Remaining Contractual Term | 1 year 9 months 18 days |
Stock Options, Exercise Price x Shares | $ | $ 328,000 |
Stock Options, Weighted Average Exercise Price | $ / shares | $ 3.20 |
Stock Options and Awards_ Sch_3
Stock Options and Awards: Schedule of Stock Options Activity (Details) - shares | 6 Months Ended | 12 Months Ended |
Jun. 30, 2019 | Dec. 31, 2018 | |
Stock Options, Outstanding | 602,500 | |
Stock Options, Granted | 9,624,133 | 500,000 |
Stock Options, Outstanding | 10,227,633 | 602,500 |
Stock Options | ||
Stock Options, Outstanding | 602,500 | |
Stock Options, Granted | 9,625,133 | |
Stock Options, Exercised | 0 | |
Stock Options, Expired/Canceled | 0 | |
Stock Options, Outstanding | 10,227,633 | 602,500 |
Weighted Average Exercise Price | ||
Stock Options, Outstanding | 2.34 | |
Stock Options, Granted | 0.16 | |
Stock Options, Exercised | 0 | |
Stock Options, Expired/Canceled | 0 | |
Stock Options, Outstanding | 1.44 | 2.34 |
Stock Options and Awards_ Defer
Stock Options and Awards: Deferred Compensation (Details) | 6 Months Ended | 12 Months Ended |
Jun. 30, 2019 USD ($) shares | Dec. 31, 2018 USD ($) shares | |
Details | ||
Stock Options, Granted | shares | 9,624,133 | 500,000 |
Stock Options, Granted, Deferred Compensation | $ 55,825 | $ 0 |
Stock Options, Granted, Deferred Compensation, Expense | 4,652 | 0 |
Stock Options, Granted, Deferred Compensation, Balance | $ 51,173 | $ 0 |
Stock Options, Remaining Amortization Period (Mos) | 34 |
Stock Options and Awards_ Restr
Stock Options and Awards: Restricted Stock Awards (Details) | 6 Months Ended | 12 Months Ended | |
Jun. 30, 2019 USD ($) shares | Jun. 30, 2018 | Dec. 31, 2018 USD ($) shares | |
Details | |||
Restricted Stock Award, Granted, Shares | shares | 0 | 1,000,000 | |
Restricted Stock Award, Granted, Value | $ 0 | $ 9,000 | |
Restricted Stock Award, Granted, Cost | $ 0 | $ 1,000 | |
Restricted Stock Award, Vested, Shares | shares | 166,667 | 83,333 | |
Restricted Stock Award, Vested, Value | $ 1,500 | $ 750 | |
Restricted Stock Award, Unvested, Shares | shares | 750,000 | 916,667 | |
Restricted Stock Award, Unvested, Deferred Compensation | $ 6,750 | $ 8,250 | |
Restricted Stock Award, Remaining Amortization Period (Mos) | 27 |
Stock Options and Awards_ Sch_4
Stock Options and Awards: Schedule of Restricted Stock Awards Activity (Details) | 6 Months Ended |
Jun. 30, 2019 shares | |
Restricted Stock Award | |
Restricted Stock Awards, Outstanding | 916,667 |
Restricted Stock Awards, Granted | 0 |
Restricted Stock Awards, Vested | (166,667) |
Restricted Stock Awards, Forfeited/Canceled | 0 |
Restricted Stock Awards, Outstanding | 750,000 |
Deferred Compensation | |
Restricted Stock Awards, Outstanding | 8,250 |
Restricted Stock Awards, Granted | 0 |
Restricted Stock Awards, Vested | (1,500) |
Restricted Stock Awards, Forfeited/Canceled | 0 |
Restricted Stock Awards, Outstanding | 6,750 |
Subsequent Events (Details)
Subsequent Events (Details) | 6 Months Ended |
Jun. 30, 2019 USD ($) $ / shares shares | |
Related Party Transactions | |
Related Party Loans, Beginning, Date | Jul. 01, 2019 |
Related Party Loans, Increase | $ 1,703,966 |
Related Party Loans, Total, Beginning | 4,300,902 |
Related Party Loans, Total, Ending | $ 6,004,868 |
Related Party Loans, Ending, Date | Dec. 31, 2022 |
Related Party Loans, Increase, Promissory Notes, Total | $ 1,703,966 |
Related Party Loans, Increase, Promissory Notes, From Non-Related Party | 110,995 |
Related Party Loans, Decrease, Promissory Notes, To Non-Related Party | 426,464 |
Related Party Loans, Increase, Promissory Notes, From Accrued Compensation | 3,849,845 |
Related Party Loans, Increase, Promissory Notes, BCF Discounts | 1,052,494 |
Related Party Loans, Decrease, Promissory Notes, Unamortized Discounts | 741,616 |
Related Party Loans, Decrease, Promissory Notes, Payments for Stock | 5,500 |
Related Party Loans, Decrease, Promissory Notes, Conversion to Stock | 521,557 |
Related Party Loans, Decrease, Promissory Notes, Payments to Related Parties | 499,975 |
Related Party Loans, Increase, Accrued Compensation, Total | 376,768 |
Related Party Loans, Increase, Accrued Compensation | 3,589,549 |
Related Party Loans, Decrease, Accrued Compensation, To Promissory Notes | 3,849,845 |
Related Party Loans, Decrease, Accrued Compensation, To Non-Related Party | 55,000 |
Related Party Loans, Decrease, Accrued Compensation, Payments for Stock | 5,500 |
Related Party Loans, Decrease, Accrued Compensation, Payments To Related Parties | 55,972 |
Related Party Loans, Increase, Reimb Exps and Cash Advances | $ 115,732 |
Related Party Transactions | Minimum | |
Related Party Loans, Interest Rates | 5 |
Related Party Loans, Convertible Notes Payable, Conversion Price | $ / shares | $ 0.05 |
Related Party Transactions | Maximum | |
Related Party Loans, Interest Rates | 7 |
Related Party Loans, Convertible Notes Payable, Conversion Price | $ / shares | $ 0.25 |
Non-Compete Agreement | |
Subsequent Event, Date | Aug. 29, 2019 |
Non-Compete Agreement, Term (Yrs) | 5 |
Non-Compete Agreement, Stock Grant, Shares | shares | 6,667,000 |
Non-Compete Agreement, Stock Grant, Shares, Value | $ 66,670 |
Non-Compete Agreement, Stock Grant, Shares, Per Share | $ / shares | $ 0.001 |
Non-Compete Agreement, Non-Dilution, Percent | 7% |
Non-Compete Agreement, Non-Dilution, End Date | May 15, 2019 |
Non-Compete Agreement | |
Subsequent Event, Date | Aug. 29, 2019 |
Non-Compete Agreement, Term (Yrs) | 5 |
Non-Compete Agreement, Stock Grant, Shares | shares | 6,667,000 |
Non-Compete Agreement, Stock Grant, Shares, Value | $ 66,670 |
Non-Compete Agreement, Stock Grant, Shares, Per Share | $ / shares | $ 0.001 |
Non-Compete Agreement, Non-Dilution, Percent | 7% |
Non-Compete Agreement, Non-Dilution, End Date | May 15, 2019 |
Stock Issuance | |
Subsequent Event, Date | Aug. 29, 2019 |
Stock Issuance, Shares | shares | 13,334,000 |
Stock Issuance, Per Share | $ / shares | $ 0.001 |
Stock Issuance, Proceeds | $ 13,334 |
Stock Issuance, Non-Dilution Provision, Shares | shares | 210,000 |
Stock Issuance, Non-Dilution Provision, Per Share | $ / shares | $ 0.001 |
Stock Issuance, Non-Dilution Provision, Proceeds | $ 210 |
Entity Formation | |
Subsequent Event, Date | Aug. 30, 2019 |
Entity Formation, Name | Enigma-Bulwark Risk Management, Inc. |
Entity Formation, State | Delaware |
Entity Formation, Stock Acquired, Percent | 100% |
Entity Formation, Stock Acquired, Entity Name | Enigma-Bulwark Security, Inc. |
Entity Formation, Stock Acquired, State | Delaware |
Consulting Agreement | |
Subsequent Event, Date | Sep. 01, 2019 |
Consulting Agreement, Issuing Subsidiary | Enigma-Bulwark Risk Management, Inc. |
Consulting Agreement, Term (Yrs) | 3 |
Consulting Agreement, Stock Options, Shares | shares | 1,250,000 |
Consulting Agreement, Stock Options, Exercise Price | $ / shares | $ 0.05 |
Consulting Agreement, Stock Options, Life (Yrs) | 5 |
Consulting Agreement, Stock Options, Vest Period (Mos) | 36 |
Consulting Agreement, Stock Options, Value, Black-Scholes, Exp Term | 5.75 |
Consulting Agreement, Stock Options, Value, Black-Scholes, Volatility | 41.30% |
Consulting Agreement, Stock Options, Value, Black-Scholes, Risk Free Int Rate | 1.84% |
Consulting Agreement, Stock Options, Value, Black-Scholes, Dividend Yield | 0% |
Consulting Agreement | |
Consulting Agreement, Compensation (Yr 1) | $ 180,000 |
Consulting Agreement, Compensation (Yr 2) | 210,000 |
Consulting Agreement, Compensation (Yr 3) | 240,000 |
Consulting Agreement, Signing Bonus | $ 25,000 |
Stock Issuance | |
Subsequent Event, Date | Sep. 20, 2019 |
Stock Issuance, Shares | shares | 4,010,470 |
Stock Issuance, Per Share | $ / shares | $ 0.005 |
Stock Issuance, Proceeds | $ 20,052 |
Consulting Agreement | |
Subsequent Event, Date | Oct. 01, 2019 |
Consulting Agreement, Term (Yrs) | 3 |
Consulting Agreement, Compensation (Yr) | $ 100,000 |
Consulting Agreement, Stock Award, Shares | shares | 1,000,000 |
Consulting Agreement, Stock Award, Shares, Value | $ 10,000 |
Consulting Agreement, Stock Award, Per Share | $ / shares | $ 0.001 |
Stock Issuance | |
Subsequent Event, Date | Oct. 01, 2019 |
Stock Issuance, Shares | shares | 1,000,000 |
Stock Issuance, Per Share | $ / shares | $ 0.001 |
Stock Issuance, Proceeds | $ 1,000 |
Stock Issuance | |
Subsequent Event, Date | Oct. 06, 2019 |
Stock Issuance, Shares | shares | 6,000,000 |
Stock Issuance, Per Share | $ / shares | $ 0.001 |
Stock Issuance, Proceeds | $ 6,000 |
Stock Issuance, Value | $ 60,000 |
Non-Compete Agreement | |
Subsequent Event, Date | Oct. 10, 2019 |
Non-Compete Agreement, Term (Yrs) | 5 |
Non-Compete Agreement, Stock Grant, Shares | shares | 4,000,000 |
Non-Compete Agreement, Stock Grant, Shares, Value | $ 360,000 |
Non-Compete Agreement, Stock Grant, Shares, Per Share | $ / shares | $ 0.001 |
Non-Compete Agreement, Non-Dilution, Percent | 4.50% |
Stock Issuance | |
Subsequent Event, Date | Oct. 10, 2019 |
Stock Issuance, Shares | shares | 4,000,000 |
Stock Issuance, Per Share | $ / shares | $ 0.001 |
Stock Issuance, Proceeds | $ 4,000 |
Stock Issuance | |
Subsequent Event, Date | Dec. 20, 2019 |
Stock Issuance, Shares | shares | 802,094 |
Stock Issuance, Per Share | $ / shares | $ 0.005 |
Stock Issuance, Proceeds | $ 4,010 |
Joint Venture | |
Subsequent Event, Date | Sep. 08, 2020 |
Joint Venture, Minority | Enigma-Bulwark Risk Management, Inc. |
Joint Venture, Majority | Prime African Security, Ltd |
Joint Venture, Name | Prime Enigma Africa (Pty) Ltd. |
Joint Venture, Majority, % | 51% |
Joint Venture, Minority, % | 49% |
Joint Venture, Term (Yrs) | 3 |
Stock Issuance | |
Subsequent Event, Date | Aug. 31, 2021 |
Stock Issuance, Shares | shares | 23,066,991 |
Stock Issuance, Conversion of Debt, Total | $ 1,238,251 |
Stock Issuance, Conversion of Debt, Amount | $ 941,096 |
Stock Issuance, Conversion of Debt, Conversion Price | $ / shares | $ 0.05 |
Stock Issuance, Conversion of Debt, Amount | $ 297,155 |
Stock Issuance, Conversion of Debt, Conversion Price | $ / shares | $ 0.07 |
Stock Issuance | |
Subsequent Event, Date | Nov. 05, 2021 |
Stock Issuance, Shares | shares | 2,785,205 |
Stock Issuance, Conversion of Debt, Amount | $ 696,301 |
Stock Issuance, Conversion of Debt, Conversion Price | $ / shares | $ 0.25 |
Stock Issuance | |
Subsequent Event, Date | Jan. 01, 2022 |
Stock Issuance, Shares | shares | 2,500,000 |
Stock Issuance, Per Share | $ / shares | $ 0.001 |
Stock Issuance, Proceeds | $ 2,500 |
Uncategorized Items - ebwk-2019
Label | Element | Value |
AOCI | ||
Comprehensive Loss | us-gaap_OtherComprehensiveIncomeLossNetOfTax | $ 0 |